تعليقThis document was developed by Annabel Baddeley and Anna Carlqvist (consultant), with inputs from Kerri Viney, Matteo Zignol and Farai Mavhunga, under the overall direction of Tereza Kasaeva, director, all at the World Health Organization (WHO) Global Tuberculosis Programme.
Experts consulted during stakeholder consultation and external review
Yousaf Ali (National TB Control Programme, Pakistan), Jamila Amin (National Tuberculosis and Leprosy Control Programme, Nigeria), Denise Arakaki Sanchez (Ministry of Health, Brazil), Anchalee Avihingsanon (Thai Red Cross AIDS Research Centre, Thailand), Helen Ayles (Zambart, Zambia), David Branigan (Treatment Action Group, United States of America), Rebeca BriceñoRobaugh (USAID, USA), Galuh Budhi Leksono Adhi (National TB Programme, Indonesia), Rachael Burke (London School of Hygiene & Tropical Medicine, Malawi / United Kingdom of Great Britain and Northern Ireland), Caterina Casalini (FHI 360, USA), Esther Casas (Médecins Sans Frontières, South Africa), Rolando Cedillos (Service of Infectious Diseases and Integrated Programme for STI/HIV/AIDS, El Salvador), Lelia Chaisson (University of Illinois at Chicago, USA), Choub Sok Chamreun (KHANA, Cambodia), Macarthur Charles (CDC, USA), Amrita Daftary (McGill University, Canada), Degu Dare (KNCV TB Plus, Kingdom of the Netherlands), Chinmoyee Das (National Aids Control Organization, India), Mitesh Desai (PEPFAR, USA), Riitta Dlodlo (The Union, Zimbabwe), Kathy Fiekert (KNCV TB Plus, Kingdom of the Netherlands), Agnes Gebhard (KNCV, Kingdom of the Netherlands), Celeste Gracia Edwards (Global Fund, Switzerland), Harry Hausler (WHO Civil Society Task Force on TB; TB HIV care, South Africa), Rian Hermana (National Aids program, Indonesia), Basharat Javed (National TB Control Programme, Pakistan), Beatriz Kamiensky (Ministry of Health, Brazil), Evaline Kibuchi (WHO Civil Society Task Force on TB, Kenya), Ole Kirk (University of Copenhagen, Denmark), Blessina Kumar (WHO Civil Society Task Force on TB, India), Endang Lukitosari (National TB Programme, Indonesia), Patrick Lungu (National Tuberculosis and Leprosy Control Program, Zambia), Judith Mariano (Disease Prevention and Control Bureau, Philippines), Enos Masini (Stop TB Partnership, Switzerland), Alberto Matteelli (University of Brescia, Italy), Sanjay Kumar Mattoo (National TB Elimination Programme, India), Tshepo Molapo (National HIV programme, South Africa), Wezi Mumba (Ministry of Health, Malawi), Paula Munderi (UNAIDS, Switzerland), Norbert Ndjeka (National TB Control Programme, South Africa), Peter Nwaokenneya (National Tuberculosis and Leprosy Control Programme, Nigeria), Archana Oinam (WHO Civil Society Task Force on TB / The Global Coalition of TB Advocates, India), Saima Paracha (National AIDS Control Programme, Pakistan), Paul Pierre (USAID, USA), Anoop Kumar Puri (National Aids Control Organization, India), Florence Riako Anam (GNP+, Kenya), Kuldeep Sachdeva (International Union Against Tuberculosis and Lung Disease, India), Hind Satti (FHI 360, USA), Suilanji Sivile (Ministry of Health, Zambia), Hannah Spencer (Médecins Sans Frontières, United Kingdom of Great Britain and Northern Ireland), Pria Subrayen (The Aurum Institute, South Africa), Gang Sun (UNAIDS, Switzerland), Aditia Taslim (INPUD, Indonesia), Monica Thormann (Ministry of Health, Dominican Republic), Emperor Ubochioma (National Tuberculosis and Leprosy Control Programme, Nigeria), Fien Vanroye (AIDS Reference Laboratory Antwerp, Belgium), Valdilea Veloso (Fundação Oswaldo Cruz, Brazil), Nyan Win Phyo (WHO Civil Society Task Force on TB, Thailand), Elena Zhdanova (National TB Centre, Kyrgyzstan).
WHO headquarters
Annabel Baddeley (Global Tuberculosis Programme), Rachael Baggaley (Global HIV, Hepatitis and STIs Programmes), Magdalena Barr-DiChiara (Global HIV, Hepatitis and STIs Programmes), Delia Boccia (Global Tuberculosis Programme), Anna Carlqvist (Global Tuberculosis Programme), Fabrizia del Greco (Global HIV, Hepatitis and STIs Programmes), Meg Doherty (Global HIV, Hepatitis and STIs Programmes), Dennis Falzon (Global Tuberculosis Programme), Nathan Ford (Global HIV, Hepatitis and STIs Programmes), Nazir Ismail (Global Tuberculosis Programme), Ernesto Jaramillo (Global Tuberculosis Programme), Cheryl Johnson (Global HIV, Hepatitis and STIs Programmes), Avinash Kanchar (Global Tuberculosis Programme), Alexei Korobitsyn (Global Tuberculosis Programme), Celine Lastrucci (Global HIV, Hepatitis and STIs Programmes), Irwin Law (Global Tuberculosis Programme), Farai Mavhunga (Global Tuberculosis Programme), Cecily Miller (Global Tuberculosis Programme), Fuad Mirzayev (Global Tuberculosis Programme), Carl-Michael Nathanson (Global Tuberculosis Programme), Morkor Newman (Global HIV, Hepatitis and STIs Programmes), Ajay Rangaraj (Global HIV, Hepatitis and STIs Programmes), Lana Syed (Global Tuberculosis Programme), Sabine Verkuijl (Global Tuberculosis Programme), Kerri Viney (Global Tuberculosis Programme), Lara Vojnov (Global HIV, Hepatitis and STIs Programmes), Elena Vovc (Global HIV, Hepatitis and STIs Programmes), Matteo Zignol (Global Tuberculosis Programme).
WHO regional and country offices staff
Omoniyi Amos (Country Office for Nigeria), Kleydson Andrade (Country Office for Brazil), Pedro Avedillo (Regional Office for the Americas), Vineet Bhatia (Regional Office for South-East Asia), Lastone Chitembo (Country Office for Zambia), Maria Regina Christian (Country Office for Indonesia), Marcelo Freitas (Country Office for Brazil), Michel Gasana (Regional Office for Africa), Aman Gupta (Country Office for India), Clarissa Halum (Country Office for Philippines), Joumana Hermez (Regional Office for the Eastern Mediterranean), Kaliya Kasymbekova (Country Office for Kyrgyzstan), Laeeq Khawaja (Country Office for Pakistan), Frank Lule (Regional Office for Africa), Nkateko Mkhondo (Country Office for South Africa), Halima Momodu (Country Office for Nigeria), Ilesanmi Oluwafunke (Country Office for Nigeria), Malik Parmar (Country Office for India), Muhammad Pasha (Country Office for Pakistan), Patrobas Dashi Philip (Country Office for Nigeria), Busisiwe Radebe (Country Office for South Africa), Kalpeshsinh Rahevar (Regional Office for the Western Pacific), BB Rewari (Regional Office for South-East Asia), Md Kamar Rezwan (Regional Office for South-East Asia), Nicole Seguy (Regional Office for Europe), Nympha Elisa Sia (Country Office for Philippines), Omar Sued (Regional Office for the Americas), Martin van den Boom (Regional Office for the Eastern Mediterranean), Askar Yedilbayev (Regional Office for Europe).
Funding from the Centers for Disease Control and Prevention (CDC) and the United States Agency for International Development (USAID) is gratefully acknowledged.